Headlines Covid-19 Specialties Trending Feeds Videos

The SARS-CoV-2 variant of concern B.1.617.2 displaced B.1.1.7 as the dominant variant in England and other countries. This study aimed to determine whether B.1.617.2...

Background: The genetic basis for coronary artery disease (CAD) risk is highly complex. Genome-wide polygenic risk scores (PRS) can help to quantify that risk,...

  • No doubt, the most unexpected finding is the inverse relationship with higher polygenic risk for coronary artery disease being associated with decreased risk for cancer across several approaches. Check out the discussion for our thoughts 🤔 8/8 https://t.co/3i86jRupLV - view on twitter

Background: The genetic basis for coronary artery disease (CAD) risk is highly complex. Genome-wide polygenic risk scores (PRS) can help to quantify that risk,...

  • Would you guess that ⬆️ polygenic risk for coronary dz is associated w/ ⬇️ dietary health score in ♀️? Or ⬇️ Gail breast cancer risk score? Check out these & many other observations about polygenic risk for CAD in our #preprint now up on #medRxiv 1/n https://t.co/3i86jRupLV - view on twitter

Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and imdevimab) that bind to two different sites on the receptor binding domain of...

Coronavirus Disease 2019 (COVID-19) remains a global health emergency with limited treatment options, lagging vaccine rates and inadequate healthcare resources in the face of...

Analysing 5,061 variant-specific tests performed on SARS-CoV-2 positive samples collected in France between 31 May and 8 June 2021 reveals a rapid growth of...

In this investigation we examined the magnitude, breadth, and durability of SARS-CoV-2 specific antibodies in two distinct B-cell compartments: long-lived plasma cell-derived antibodies in...

  • "more specific and what about these darn variants". Then I will tell you about this amazing paper published by OHSU recently which mildly says "Unease has arisen over the past several months with the emergence of specific CDC-defined variants of concern" https://t.co/kE5SN2Pbl3 - view on twitter

Vaccines against SARS-CoV-2 have shown high efficacy, but immunocompromised participants were excluded from controlled clinical trials. We evaluated immune responses to the Pfizer/BioNTech mRNA...

Studies describing SARS-CoV-2 immune responses following mRNA vaccination in hematology malignancy (HM) patients are virtually non-existent. We measured SARS-CoV-2 IgG production in 67 HM...

Vaccines against SARS-CoV-2 have shown high efficacy, but immunocompromised participants were excluded from controlled clinical trials. We evaluated immune responses to the Pfizer/BioNTech mRNA...